Target Details
| UniProt AC | P31751 |
|---|---|
| Gene Symbol | AKT2 |
| Protein Name | RAC-beta serine/threonine-protein kinase |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00169 (PH) PF00069 (Pkinase) PF00433 (Pkinase_C) |
Summary
- Multi-target molecules 896
- Clinical molecules 7
- Avg pChEMBL 7.35
KEGG Pathways (103)
- AGE-RAGE signaling pathway in diabetic complications
- AMPK signaling pathway
- Acute myeloid leukemia
- Adipocytokine signaling pathway
- Adrenergic signaling in cardiomyocytes
- Alcoholic liver disease
- Alzheimer disease
- Apelin signaling pathway
- Apoptosis
- Autophagy - animal
- B cell receptor signaling pathway
- Breast cancer
- C-type lectin receptor signaling pathway
- Carbohydrate digestion and absorption
- Cellular senescence
- Central carbon metabolism in cancer
- Chagas disease
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- Choline metabolism in cancer
- Cholinergic synapse
- Chronic myeloid leukemia
- Colorectal cancer
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endometrial cancer
- Epstein-Barr virus infection
- ErbB signaling pathway
- Estrogen signaling pathway
- Fc epsilon RI signaling pathway
- Fc gamma R-mediated phagocytosis
- Fluid shear stress and atherosclerosis
- Focal adhesion
- FoxO signaling pathway
- Gastric cancer
- Glioma
- Glucagon signaling pathway
- GnRH secretion
- Growth hormone synthesis, secretion and action
- HIF-1 signaling pathway
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Herpes simplex virus 1 infection
- Human T-cell leukemia virus 1 infection
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- Human papillomavirus infection
- IgSF CAM signaling
- Influenza A
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- JAK-STAT signaling pathway
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Longevity regulating pathway
- Longevity regulating pathway - multiple species
- MAPK signaling pathway
- Measles
- Melanoma
- Neurotrophin signaling pathway
- Neutrophil extracellular trap formation
- Non-alcoholic fatty liver disease
- Non-small cell lung cancer
- Osteoclast differentiation
- PD-L1 expression and PD-1 checkpoint pathway in cancer
- PI3K-Akt signaling pathway
- Pancreatic cancer
- Pathways in cancer
- Phospholipase D signaling pathway
- Platelet activation
- Platinum drug resistance
- Progesterone-mediated oocyte maturation
- Prolactin signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Regulation of lipolysis in adipocytes
- Relaxin signaling pathway
- Renal cell carcinoma
- Salmonella infection
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- Small cell lung cancer
- Sphingolipid signaling pathway
- Spinocerebellar ataxia
- T cell receptor signaling pathway
- TNF signaling pathway
- Thyroid hormone signaling pathway
- Toll-like receptor signaling pathway
- Toxoplasmosis
- Tuberculosis
- VEGF signaling pathway
- Yersinia infection
- cAMP signaling pathway
- cGMP-PKG signaling pathway
- mTOR signaling pathway
Associated Diseases (4)
Active Molecules (896)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
PPMXORITWNSKAE
|
8.4 | IC50 | 2 | — | |
YZFPZLRYEFAFRR
|
8.4 | IC50 | 2 | — | |
ZUILYPNRYTWPOX
|
8.4 | IC50 | 2 | — | |
QJQZFOLVUJYZMK
|
8.4 | IC50 | 2 | — | |
ALUYNNMYLAIVQS
|
8.4 | IC50 | 5 | — | |
HNFMVVHMKGFCMB
|
8.3 | IC50 | 3 | — | |
YFXZFROOGCONFB
|
8.3 | IC50 | 4 | — | |
WVJKVFMFFXKXKV
|
8.3 | IC50 | 2 | — | |
GIAKGRDDSYYQQS
|
8.3 | IC50 | 5 | — | |
NUBMYVASWBXGEZ
|
8.3 | IC50 | 6 | — | |
RFIULMNQQUABKQ
|
8.3 | IC50 | 3 | — | |
TUKDHYPEOCEIMO
|
8.3 | IC50 | 2 | — | |
ZCCPLJOKGAACRT
|
8.3 | Kd | 599 | — | |
AWQLNADWVBCMHO
|
8.3 | IC50 | 2 | — | |
DFURSNCTQGJRRX
|
8.3 | IC50 | 3 | — | |
KCWPSUKJCKZEAO
|
8.3 | IC50 | 2 | — | |
KCWSEQZHIICHPH
|
8.3 | IC50 | 2 | — | |
KLSYPIQWMFSSJW
|
8.3 | IC50 | 8 | — | |
KYCYRGUYNYCBAH
|
8.3 | IC50 | 7 | — | |
NXUWGUQHCIIYBD
|
8.3 | IC50 | 2 | — | |
OSDYJCFGRBVWAT
|
8.3 | IC50 | 3 | — | |
PANBKHQUCFTTQA
|
8.3 | IC50 | 2 | — | |
WIWPGJGLUKQUKV
|
8.3 | IC50 | 2 | — | |
XMRDIROQMJMYRD
|
8.3 | IC50 | 4 | — | |
HSHUBMQAZCRYQJ
|
8.3 | IC50 | 2 | — | |
KGMSOGZPKIKVMJ
|
8.3 | IC50 | 2 | — | |
NLPSLEFOKSDSPL
|
8.3 | IC50 | 2 | — | |
DOJSODPNZWPNBR
|
8.2 | IC50 | 3 | — | |
DRPJZMIFBAXAKX
|
8.2 | IC50 | 3 | — | |
GHUNSPMEIRXTBW
|
8.2 | Ki | 3 | — | |
JHMAEWUXAYBMPA
|
8.2 | IC50 | 3 | — | |
JVKUGJVIBUMCFL
|
8.2 | IC50 | 3 | — | |
KFUFYKHPONJLKZ
|
8.2 | IC50 | 5 | — | |
MTIVHEGAZSBQQQ
|
8.2 | IC50 | 3 | — | |
NEEIYKGPXDSGBL
|
8.2 | IC50 | 3 | — | |
PFPJHXYCUWHBHV
|
8.2 | IC50 | 2 | — | |
ROHAVZMZAUESFZ
|
8.2 | IC50 | 3 | — | |
RZIDZIGAXXNODG
|
8.2 | IC50 | 5 | — | |
WTDXONBSQHCAGP
|
8.2 | IC50 | 2 | — | |
WWGYSLWSIAEYKJ
|
8.2 | IC50 | 3 | — | |
XDQKFRGGLYEIJJ
|
8.2 | IC50 | 3 | — | |
PQASUWRZUBDZDW
|
8.2 | IC50 | 3 | — | |
RXNPEQZHMGFNAY
|
8.2 | IC50 | 3 | — | |
UMTWTCVTRDYHQQ
|
8.2 | Ki | 56 | — | |
BYUYFBPVWISNOX
|
8.2 | IC50 | 2 | — | |
HUDQBWLADGWETM
|
8.2 | IC50 | 4 | — | |
LHQWPYOYDRVMFI
|
8.2 | IC50 | 10 | Yes | |
VLYIIJVXJVEICJ
|
8.2 | IC50 | 3 | — | |
WCBMSENIXPZAJT
|
8.2 | IC50 | 4 | — | |
WZXPKDANYCNRFJ
|
8.2 | IC50 | 3 | — |